Irisin inhibits Smad3 phosphorylation-mediated ferroptosis and fibrosis, leading to significant alleviation of renal tubular cell injury and fibrotic lesions in UUO, as revealed by results [168]
It is the acetylated form of l-carnitine, and the two compounds share similar energy- and metabolism-promoting properties
Endocrinology 162 , bqab079 (2021)
Efficacy many companies, such as Eli Lilly or Zealand Pharma, are working on improving efficacy in terms of percentage weight loss or focussing on specific sub-niches, like liver diseases
this drug has Investigational New Drug clearance from the U.S
Supplied as lyophilised powder for in-vitro research use only, not a licensed medicine, and no therapeutic, cosmetic or appearance claim is made or implied